JTT-501, a Novel Oral Antidiabetic Agent, Improves Insulin Resistance in Genetic and Non-Genetic Insulin-Resistant Models

British Journal of Pharmacology - United States
doi 10.1038/sj.bjp.0702253
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Hope for Insulin Mimetic Oral Antidiabetic Drugs

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1999English

A Novel Antidiabetic Monomers Combination Alleviates Insulin Resistance Through Bacteria-Cometabolism-Inflammation Responses

Frontiers in Microbiology
Microbiology
2020English

Oral Vanadyl Sulfate Improves Hepatic and Peripheral Insulin Sensitivity in Patients With Non-Insulin-Dependent Diabetes Mellitus.

Journal of Clinical Investigation
Medicine
1995English

Pravastatin Improves Insulin Resistance in Dyslipidemic Patients

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2005English

Cardiovascular Safety of Oral Antidiabetic Agents: The Insulin Secretagogues

Clinical Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

The Role of Insulin Resistance in Experimental Diabetic Retinopathy—Genetic and Molecular Aspects

PLoS ONE
Multidisciplinary
2017English

Estimating Genetic and Non-Genetic Components of Variance for Fasting Glucose Levels in Pedigrees Ascertained Through Non-Insulin Dependent Diabetes

Annals of Human Genetics
Genetics
1982English

Antidiabetic Effects of Bitter Gourd Extracts in Insulin-Resistant Db/Db Mice

British Journal of Nutrition
MedicineNutritionDietetics
2010English

Oral Administration of Bifidobacterium Spp. Improves Insulin Resistance, Induces Adiponectin, and Prevents Inflammatory Adipokine Expressions

Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy